Top 35 Life Science VC Funds & Investors in Oceania (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Main Sequence Ventures
VC Fund
|
3 | Australia, United States, Philippines | Seed, Series A, Series B | Software, Artificial Intelligence, Manufacturing | $1M–$73M |
|
New Zealand Green Investment Finance
VC Fund
|
3 | New Zealand, Australia, United Kingdom | Debt Financing, Seed, Venture - Series Unknown | Energy, Solar, Sustainability | $372k–$49M |
|
Catalio Capital Management
VC Fund
|
2 | United States, Switzerland, Israel | Series A, Series B | Biotechnology, Health Care, Life Science | $15M–$150M |
|
Tin Alley Ventures
VC Fund
|
2 | Australia, Philippines | Pre-Seed, Seed, Series B | Biotechnology, Medical, Software | $430k–$2.9M |
|
AgriZeroNZ
VC Fund
|
2 | United States, New Zealand, Sweden | Seed, Series A, Venture - Series Unknown | Biotechnology, AgTech, Animal Feed | $677k–$27M |
|
Medical Research Commercialisation Fund (MRCF)
VC Fund
|
1 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $1.3M–$16M |
|
Riverlane Capital
VC Fund
|
1 | Australia | Series A | Life Science, Biotechnology, Venture Capital | |
|
Possible Ventures
VC Fund
|
1 | Germany, Australia, United States | Seed, Pre-Seed, Series A | Software, Biotechnology, Information Technology | $549k–$47M |
|
Marex
VC Fund
|
1 | New Zealand | Series A | Life Science, Biotechnology | |
|
Cultivate Ventures
VC Fund
|
1 | New Zealand, United States | Seed, Series A | Biotechnology, Mobile, Sensor | $3.9M–$9.6M |
|
Third Hemisphere
VC Fund
|
1 | Australia | Seed | Aquaculture, Life Science, Biotechnology | |
|
Digitalis Ventures
VC Fund
|
1 | United States, United Kingdom, China | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $1.5M–$132M |
|
Regeneration.VC
VC Fund
|
1 | United States, United Kingdom, The Netherlands | Series A, Seed, Series B | Manufacturing, Machine Learning, Fashion | $2M–$30M |
|
Centre for Climate Action Joint Venture
VC Fund
|
1 | New Zealand | Seed | Life Science, Biotechnology | |
|
Time Ventures
VC Fund
|
1 | United States, Canada, Germany | Series A, Series B, Seed | Software, Information Technology, Artificial Intelligence | $2.9M–$450M |
|
Paul Little’s family office
VC Fund
|
1 | Australia | Seed | E-Commerce, Real Estate, Decentralized Finance (DeFi) | |
|
Parkview International
VC Fund
|
1 | United States | Series C | Pet, Medical, Veterinary | |
|
Bioplatforms Australia
VC Fund
|
1 | Australia | Pre-Seed | AgTech, Farming, Agriculture | |
|
Alberici
VC Fund
|
1 | Australia | Seed | Real Estate, Life Science, Property Management | |
|
The March Group
VC Fund
|
1 | United States, Denmark, Australia | Series A, Seed, Series C | Biotechnology, SaaS, AgTech | $4.7M–$33M |
|
Accelerating Commercialisation - AusIndustry
VC Fund
|
1 | Australia | Grant, Pre-Seed | Software, SaaS, Mining | $156k–$267k |
|
Uniseed Ventures
VC Fund
|
1 | Australia, United States, United Kingdom | Series A, Seed | Biotechnology, Health Care, Manufacturing | $381k–$16M |
|
Skalata
VC Fund
|
1 | Australia, United States, United Kingdom | Pre-Seed, Seed | Software, Education, Information Technology | $129k–$2.3M |
|
Breakthrough Victoria
VC Fund
|
1 | Australia, United States, Philippines | Seed, Series A, Venture - Series Unknown | Health Care, Manufacturing, Biotechnology | $600k–$30M |
|
Uniseed
VC Fund
|
1 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Manufacturing | $471k–$22M |
|
Alium Capital
VC Fund
|
1 | Australia, United States, Singapore | Series A, Series B, Seed | Software, Financial Services, Apps | $500k–$465M |
|
Flintco, LLC
VC Fund
|
1 | Australia | Seed | Real Estate, Life Science, Property Management | |
|
OneVentures
VC Fund
|
1 | Australia, United States, Israel | Series A, Debt Financing | Software, Health Care, Biotechnology | $1M–$20M |
|
AbbVie Biotech Ventures
VC Fund
|
1 | United States, China, Italy | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6M–$115M |
|
Antler
VC Fund
|
1 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $108k–$28M |
|
Brandon Capital
VC Fund
|
1 | Australia, United Kingdom, United States | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $673k–$115M |
|
ONE Innovators
VC Fund
|
1 | Japan, Australia | Seed, Series A, Series B | AgTech, Sensor, Farming | |
|
Icehouse Ventures
VC Fund
|
1 | New Zealand, United States, United Kingdom | Seed, Series A | Software, SaaS, Information Technology | $612k–$16M |
|
Rosrain Investments
VC Fund
|
1 | New Zealand | Series A | Life Science, Biotechnology | |
|
Churchill Asset Management
VC Fund
|
1 | United States, Canada, Australia | Debt Financing, Private Equity, Series A | Health Care, Manufacturing, Insurance | |
| Access all 35 VC funds in Oceania Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Manufacturing
- Stage:Seed, Series A, Series B
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 127
- Round size: Seed $1M–$7M; Series A $4.5M–$29M; Series B $13M–$73M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $303M in 2023
Portfolio highlights
- Swoop Aero — Transforming how the world moves by making access to the skies seamless. Kite Aero is the only end-to-end drone logistics platform on the planet. We unlock the potential of the sky, for the good of us all. Currently we serve over 4.5 million people in 6 continents. By 2030, our reach will extend to 1 billion.
- Loam Bio — Loam has designed farmer-focused carbon projects that support farmers to build stable soil carbon in cropping and mixed farming systems.
- Castlepoint Systems — Startux X is the perfect multi-purpose Startup Webflow Template. Get it today and design a state-of-the-art website for your technology startup or company in record time.
New Zealand Green Investment Finance provides support to the growth of innovative energy and carbon management.
Show more...Investment focus
- Industry: Energy, Solar, Sustainability
- Stage:Debt Financing, Seed, Venture - Series Unknown
- Geography: New Zealand, Australia, United Kingdom
Investor stats
- Total investments: 26
- Round size: Seed $3.7M–$7.6M; Debt Financing $644k–$49M; Venture - Series Unknown $372k–$3.2M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- ESP —
- Carbn Group — Carbn Group is a car fleet management company that makes car fleet services sustainable and accessible to more users.
- Zenobe Energy — Zenobe Energy ( formerly known as Battery Energy Storage Solutions Limited) is the largest independent owner and operator of battery storage in the UK. We transform the way grid operators and businesses use power to reduce costs, improve reliability and benefit the environment.
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B
- Geography: United States, Switzerland, Israel
Investor stats
- Total investments: 129
- Round size: Series A $15M–$150M; Series B $26M–$150M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- OSPRI — Multiplex qPCR reagent kits for assay development, biomarker discovery, and translational research. 120+ configurations across a broad range of research areas. Extraction-free. Customizable. For Research Use Only.
- Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
- Medical Informatics — Medical Informatics offers solutions that give care teams access to the data they need to take action for alarm management and safety. The company’s Sickbay software platform enables continuous data collection from a comprehensive set of devices. Ultimately their alarm management solutions reduce alarm noise at the patient level, and send the rightalarms to care providers.Medical Informatics Corp was founded by Emma Fauss and Craig Rusin in 2010 and is based in Houston, Texas.
Tin Alley Ventures collaborates with companies and researchers in the University of Melbourne's ecosystem to invest in & support world-changing businesses.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Pre-Seed, Seed, Series B
- Geography: Australia, Philippines
Investor stats
- Total investments: 7
- Round size: Pre-Seed $430k–$2.9M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- i14 — We are i14 — we sit at the intersection of Computational Cognitive Science and AI research, and have developed a new class of models called Laplace Sequence Models that are an order of magnitude faster and more efficient and multiples more accurate than the transformer. We’ve also built a foundation model platform that allows organisations tocreate private, domain-specific expert models deployable across any environment (on-prem, at the edge, on device, in a private cloud, or hosted by i14). Our research lab continues to push beyond many of the limitations of current AI, and has a host of research projects which are continually integrated to update our foundation model platform. We recently closed a $4M initial round and are preparing for the next round.
- Mirugen — Mirugen is a preclinical biotechnology company identifying the optimal set of cellular instructions to ask one cell type to become another.
- Kronus — Full-stack development infrastructure for safety-critical systems.
AgriZeroNZ is a world-first public-private partnership helping farmers reduce emissions while maintaining profitability and productivity.
Show more...Investment focus
- Industry: Biotechnology, AgTech, Animal Feed
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, New Zealand, Sweden
Investor stats
- Total investments: 16
- Round size: Seed $677k–$10M; Series A $7M–$27M; Venture - Series Unknown $3M–$14M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- Rumin8 — Rumin8 - Solving livestock methane emissions
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
- Āmua Innovation —
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 26
- Round size: Series A $1.3M–$13M; Series B $6.4M–$16M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- MycRx — MecRx is a drug development company that works on new treatments for cancer and novel mechanism of action antibiotics. Using proprietary “hit identification” technology, MecRx is developing inhibitors of cMyc, a protein that is deregulated in over 50% of all human cancers. MecRx draws on the expertise of the Peter MacCallum Cancer Centre and CSIROand is headquartered in Melbourne, Australia.MecRx was founded in 2013 by an ex-pharma/biotech team. MecRx is run as a virtual company based in Melbourne, Australia and its shareholders and service providers include the Peter MacCallum Cancer Institute and CSIRO. The company secured $5m Series A investment from the MRCF (www.mrcf.com.au) and CSIRO in 2015.
- Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Long-term owner-operators of great Australian businesses.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Venture Capital
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Australia, United States
Investor stats
- Total investments: 163
- Round size: Seed $1.6M–$10M; Pre-Seed $549k–$3.8M; Series A $9.7M–$47M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- EntryLevel — Learn in an affordable, peer-driven environment over 6 weeks with mentors from top companies across the world such as Atlassian, Wise and more.
- VSPARTICLE — VSPARTICLE develops nanoparticle generators for various applications such as sensors, batteries, catalysis, solar cells, healthcare, additive manufacturing, nano safety, and more. It also enables research and industry to generate new materials at the push of a button.They specialize in nanoparticle production and integration. The technologyspeeds up the developments of customers by producing the desired nanoparticles on location and integrate them directly in the final product. VSPARTICLE was founded in 2014 and is headquartered in Delft, The Netherlands.
- Omeda Studios — Developing Predecessor, a Third Person Multiplayer Online Battle Arena game for PC and console.
Marex.com is a provider of business-to-business e-commerce solutions for the marine industry offers a proprietary set of procurement solutions.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Series A
- Geography: New Zealand
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
- Key Carbon — Carbon Neutral Royalty operates a permanent capital vehicle designed to finance projects in the Voluntary Carbon Markets (VCM) through a prepayment in exchange for a portion of future carbon credits. The company specializes in financial support for the project and sells carbon credits to corporations that have made net zero pledges to help themmeet their climate, biodiversity, and community commitments.Carbon Neutral Royalty was established in July, 2021 in Vancouver, British Columbia.
Cultivate Ventures is an investment and advisory firm built to catalyze growth for promising food, wellness and fitness companies. We focus specifically on investment, business concept incubation, seed-to-growth stage acceleration and turn around advisory services. We believe strongly in strong returns on capital combined with collaboration,transparency, conscious consumerism. We take a long-term, collaborative and flexible approach to each company and client we work with and invest in, allowing our financial and operational stake to grow as our partners grow.
Show more...Investment focus
- Industry: Biotechnology, Mobile, Sensor
- Stage:Seed, Series A
- Geography: New Zealand, United States
Investor stats
- Total investments: 5
- Round size: Seed $3.9M–$7M; Series A $7.3M–$9.6M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Hectre — Award winning, simple to use orchard apps for performance and cost management optimization.
- Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Third Hemisphere is a technology and finance communications firm for innovators and leaders who are breaking new ground.
Show more...Investment focus
- Industry: Aquaculture, Life Science, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Fremantle Seaweed — Fremantle Seaweed is growing native seaweed types at a trial farm south of Gage Roads.
Engineering solutions to complex problems in health through venture investment and company creation.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 105
- Round size: Seed $1.5M–$16M; Series A $7.5M–$66M; Series B $13M–$132M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Somatix — A fully comprehensive monitoring solution with unique smartband technology. Solutions for SNFs, senior living, healthcare systems, and smoking cessation.
- Girihlet — Girihlet is a provider of rapid and accurate deep sequencing services with a unique focus on developing novel technologies. Girihlet currently specializes in inexpensively sequencing and analyzing mtDNA and T cell receptors using novel, bias-free methods in order to harness their power as biomarkers for diagnostics in a variety of disorders.
- Neion Bio — Neion Bio uses advances in stem cell biology and genetic engineering to completely reimagine the biopharmaceutical production process.
Founded in Los Angeles, Regeneration.VC is an early-stage venture fund supercharging consumer-powered climate innovation driven by circular and regenerative principles. Our investment strategy encompasses design (materials & packaging), use (consumer brands & products), and reuse technologies (reverse logistics & marketplaces) thatgenerate measurable environmental impact alongside outsized return potential.
Show more...Investment focus
- Industry: Manufacturing, Machine Learning, Fashion
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 23
- Round size: Seed $2M–$7.6M; Series A $5.6M–$30M; Series B $18M–$24M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $45M in 2022
Portfolio highlights
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- CleanO2 — CleanO2 Carbon Capture Technologies is set to change the heating industry. In 2007, the founders of CleanO2 CCT began developing technology that would have a positive impact in the industry. Now, 9 years later, the company have deployed the residential carbon capture device in Alberta, Canada and have expanded the technology on a global scale.Thecompany has developed an aggregated commercial carbon capture device called CARBiNX, a sleek, carbon munching addition to businesses. Reducing energy demands through heat recovery and using the carbon capture process to create a valuable by-product.CleanO2 Carbon Capture Technologies was founded on 2013 and is headquartered in Calgary, Alberta, Canada.
- Cruz Foam — Cruz Foam offers certified compostable, protective packaging foam and other solutions. Let us help you transition to compostable foam packaging solutions, today.
Centre for Climate Action Joint Venture focuses on investment and effort in tackling New Zealand’s Agricultural emissions to meet reduction targets
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: New Zealand
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
Time Ventures is an investment fund for Marc Benioff. The company looks to invest in theB2B, hospitality, non-financial services, and commercial products and services sectors.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 50
- Round size: Seed $2.9M–$450M; Series A $11M–$80M; Series B $37M–$140M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Laurel — Time by Ping frees lawyers from timekeeping so they can focus on their work, and firms can understand where time is being spent.
- MoonPay — MoonPay offers a fast and simple way to buy and sell cryptocurrencies. Buy crypto with credit card, bank transfers or Apple Pay today.
- Regrow Ag — At Regrow, we empower farmers and partners to transform agriculture, build regenerative practices and combat climate change.
Paul Little’s family office operates as an investment firm.
Show more...Investment focus
- Industry: E-Commerce, Real Estate, Decentralized Finance (DeFi)
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
- EstateXchange — Simplest way to settle deceased estates securely. Save time with estates administration. For lawyers, banks & more. Deliver faster outcomes for all.
Parkview International operates as a single-family office.
Show more...Investment focus
- Industry: Pet, Medical, Veterinary
- Stage:Series C
- Geography: United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Petfolk — Petfolk's world-class animal hospitals & pet care centers offer virtual, in-person & urgent veterinary care with a pet-parent-focused approach. Learn more!
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
Bioplatforms Australia is a non-profit entity that supports life science research in genomic, proteomics, metabolomics, and bioinformatics.
Show more...Investment focus
- Industry: AgTech, Farming, Agriculture
- Stage:Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Number 8 bio — Number 8 Bio is a scientist-led start-up in Sydney that makes scalable and affordable enteric methane mitigation feed additives for livestock. We have a unique approach to managing rumen energy flows and animal productivity when methane is decreased, and we aim to give farmers a healthy ROI when using the additives.
Alberici is a diversified construction company recognized for superior quality and customer service. With operations throughout North America and clients around the world, they offer general contracting, construction management, and design-build solutions across a broad spectrum of industrial and commercial markets.
Show more...Investment focus
- Industry: Real Estate, Life Science, Property Management
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- LCG Capital Management — LCG Capital Management delivers expert real estate solutions, from property management in St. Louis, MO, to asset management & development.
A venture capital fund platform committed to supporting and investing in entrepreneurs and companies developing and bringing exponential technologies to food, health and sustainability. March's investment strategy involves becoming recognized as the leading investor in critical and transformative technology solutions, and aims to achieve thisby investing into companies and funds that focus on developing core intellectual property around game-changing sustainable solutions that are aligned with globally relevant sustainability trends and benefits.
Show more...Investment focus
- Industry: Biotechnology, SaaS, AgTech
- Stage:Series A, Seed, Series C
- Geography: United States, Denmark, Australia
Investor stats
- Total investments: 7
- Round size: Seed $4.7M–$4.8M; Series A $7.2M–$33M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $2.1M in 2019
Portfolio highlights
- Digestiva — We amplifye Protein.
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- Number 8 bio — Number 8 Bio is a scientist-led start-up in Sydney that makes scalable and affordable enteric methane mitigation feed additives for livestock. We have a unique approach to managing rumen energy flows and animal productivity when methane is decreased, and we aim to give farmers a healthy ROI when using the additives.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A grant program offered by AusIndustry as part of the Australian Government’s National Innovation and Science Agenda
Show more...Investment focus
- Industry: Software, SaaS, Mining
- Stage:Grant, Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 3
- Round size: Grant $156k–$267k
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Getmee — Getmee is an AI employability and communication coach. The product suite contains a branded mobile app for Android and iOS Smartphones as well as an LMS for enterprises. Getmee currently supports over 50,000 clients in Australia, the UK and Mexico.
- Neuromersiv — Combining Virtual Reality, haptics and functional electrical stimulation, Neuromersiv is revolutionising brain rehabilitation therapy.Using a proprietary wearable device paired with a VR headset, Neuromersiv provides an engaging, immersive therapy experience in which patients perform gamified tasks ranging from picking up a toothbrush to climbingEverest! This unique approach increases dopamine activity in the brain, enhancing neuroplasticity, which is the brain’s ability to form new neural connections. Early trials of Neuromersiv technology have demonstrated 3x better outcomes as compared to traditional rehabilitation therapy resulting in faster independence and reduced care costs.
- Tiny Bright Things — Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape ofpowders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent).
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $381k–$4.2M; Series A $1.3M–$16M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $14M in 2017
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Giving Australian founders access to the education, capital and networks needed to build significant, sustainable, global businesses of the future.
Show more...Investment focus
- Industry: Software, Education, Information Technology
- Stage:Pre-Seed, Seed
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 86
- Round size: Seed $135k–$2.3M; Pre-Seed $129k–$500k
- Lead/follow: 80% lead, 20% follow
- Last fund: Likely still investing — raised $18M in 2021
Portfolio highlights
- Paperly — Paperly is an mobile app that provides modules for school management system and learning management system.
- Cor — Obi by Cor is the leading voice AI agent for customer onboarding and user activation. It uses voice and on-screen awareness to guide users, share best practices, and answer questions in real time.
- BarterAds Pty Ltd — BarterAds is a programmatic advertising exchange that enables businesses to acquire customers without cash spend by converting unused ad inventory into a tradable asset. Instead of paying in fiat, companies earn and spend a proprietary internal currency called Barter Dollars, which are issued when they display ads on their owned media propertiessuch as websites, apps, or platforms.The platform operates as an auction-based exchange, similar to traditional ad networks, where advertisers bid for impressions using Barter Dollars. Inventory is matched contextually and priced dynamically through real-time bidding, ensuring efficient allocation of supply and demand across the network. This allows both advertisers and publishers to maximize the value of otherwise underutilized inventory.BarterAds primarily targets startups, SaaS platforms, marketplaces, gaming companies, and content publishers that have traffic but are constrained by rising customer acquisition costs. By removing the need for upfront cash spend, the platform provides a capital-efficient growth channel, particularly for small and mid-sized businesses.The system includes controls for brand safety, fraud prevention, and inventory quality through business verification, campaign approvals, and continuous monitoring. Barter Dollars are non-transferable and expire periodically, preventing hoarding and ensuring continuous circulation within the ecosystem.BarterAds is designed as a hybrid between barter networks and modern ad exchanges, combining the scalability and automation of programmatic advertising with a closed-loop, cashless economy. The company is headquartered in Australia and is focused on building a global network of advertisers and publishers who both contribute inventory and run campaigns within the platform.
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 52
- Round size: Seed $708k–$6.8M; Series A $1.7M–$30M; Venture - Series Unknown $600k–$30M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- DeepDerm — DeepDerm is developing AI-enabled cameras that detect skin cancer without the need for painful biopsies.
- AlleSense — AlleSense develops a label-free optical imaging technology designed to enhance disease diagnosis by manipulating light-tissue interactions at the nanoscale. It's Mission is to Reimagining the standard microscope slide to make digital pathology faster, more accurate, and accessible without complex chemical staining.
- Deftbiotech — Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 86
- Round size: Seed $600k–$3.5M; Series A $1.6M–$16M; Series B $471k–$22M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- DeteQt — Semiconductor chip-based quantum magnetic field sensors using diamond - navigation, mining, medical imaging
- Plasmaleap —
- Analog Quantum Circuits — Analog Quantum Circuits develops analog components for solid-state quantum computers.
Alium Capital focuses on listed and unlisted technology investments to generate out-sized returns. The company invests in technology, innovation, and early-stage businesses, all the way through to publicly listed assets. It specializes in the fields of finance, investing, innovation, and capital.Alium Capital was founded in 2016 andheadquartered in Sydney, New South Wales.
Show more...Investment focus
- Industry: Software, Financial Services, Apps
- Stage:Series A, Series B, Seed
- Geography: Australia, United States, Singapore
Investor stats
- Total investments: 40
- Round size: Seed $4.5M–$10M; Series A $500k–$13M; Series B $2M–$465M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — raised $72M in 2017
Portfolio highlights
- Academy Xi — At Academy Xi, we help APAC's largest and most sophisticated organisations optimise performance with concise, actionable training solutions.
- DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,328,201 freelance designers compete to create amazing designs for your business. Start Today!
- York Street Brands — York Street Brands, formed by the merger of Boost Lab and tbh Skincare specializes in serums that target a range of skin concerns.
Flintco provides innovative construction solutions with an unrelenting focus on quality, safety, cost and schedule.
Show more...Investment focus
- Industry: Real Estate, Life Science, Property Management
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LCG Capital Management — LCG Capital Management delivers expert real estate solutions, from property management in St. Louis, MO, to asset management & development.
OneVentures is a later-stage venture capital firm focused on scaling Technology and Healthcare companies through growth equity and credit. The firm's role extends far beyond investment, as the firm actively guides companies toward achieving their next critical milestones. By leveraging decades of global experience and operational expertise,OneVentures accelerates growth and helps shape the future of its portfolio companies.A global growth focus drives their investment selection, with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Debt Financing
- Geography: Australia, United States, Israel
Investor stats
- Total investments: 80
- Round size: Series A $1.5M–$20M; Debt Financing $1M–$6.7M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $145M in 2022
Portfolio highlights
- me&u — me&u is an online ordering and payment application designed to order meals. They provide communication technology to order and pay through mobile phones at restaurants. Their process of ordering with waiters and splitting bills that enable users to order their food and pay bills through a digital payment platform.
- Truescope — Make better informed communications decisions with Truescope. Harnessing millions of media posts every day to deliver you real-time information that influences your business strategy.
- Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Togetherwith its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, Italy
Investor stats
- Total investments: 49
- Round size: Series A $6M–$53M; Series B $12M–$85M; Series C $39M–$115M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Mozart Therapeutics — The company intended to focus on developing novel immune engagers.
- Quanta Therapeutics — Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes. The company was founded in 2018 and is based in San Francisco, CA.
- DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 1818
- Round size: Seed $186k–$4.6M; Pre-Seed $108k–$750k; Series A $4.6M–$28M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely actively investing — fresh fund, raised $72M in 2024
Portfolio highlights
- Sapyen — We take the fear out of infertility for men. Test for it at home, without stepping out to the hospital and get personalised health recommendations to improve sperm health and increase your chances of conceiving.
- Visoid — Render your 3D models with ease! Quick and easy rendering software for architects, powered by AI. Try Visoid for free!
- One Key Access — One Key Access is an interface to the world of couriers to enable 24/7 frictionless deliveries.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 69
- Round size: Seed $673k–$6.7M; Series A $4.9M–$115M; Series B $6.4M–$68M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $210M in 2019
Portfolio highlights
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
- NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
The global imperative of achieving net-zero emissions by 2050 demands innovative solutions across all nations, including Japan. Recognizing this urgency, ONE Innovators has established a dedicated venture capital fund focused on the carbon-neutral sector.
Show more...Investment focus
- Industry: AgTech, Sensor, Farming
- Stage:Seed, Series A, Series B
- Geography: Japan, Australia
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Archeda — Archeda is an IT firm that analysis of natural environments using remote sensing data.
- Number 8 bio — Number 8 Bio is a scientist-led start-up in Sydney that makes scalable and affordable enteric methane mitigation feed additives for livestock. We have a unique approach to managing rumen energy flows and animal productivity when methane is decreased, and we aim to give farmers a healthy ROI when using the additives.
- Girasol Energy — Girasol Energy is an IoT Platform provides innovative PLC technologies that enable wiser PV Plants.
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 209
- Round size: Seed $612k–$5M; Series A $2.2M–$16M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely still investing — raised $69M in 2021
Portfolio highlights
- Vessev — Vessev is a maritime trasportantion company that offers hydrofoiling electric vessels for travelling through water.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Dotterel Technologies — Dotterel develops noise reduction and audio recording technology for UAVs. Our Aerial Audio Microphone is a payload for UAVs and is a unique world first capability. Throughout the development we have worked closely with customers to deliver for high value use cases in Emergency Services, Defence and TV/Film. Hearing audio from your UAV provides an important addition to the video. Now you can have live conversations one-to-one and one-to-many with people remotely via the UAV when there is no other communication methods available. We look forward to working with our customers and partners to deliver a new range of UAV solutions.
Rosrain Investments is an investment firm.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Series A
- Geography: New Zealand
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.
Churchill is a leading capital provider for private equity-owned, middle market companies. We provide first lien, unitranche, second lien and mezzanine debt, in addition to equity co-investments, secondary solutions and private equity fund commitments.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Insurance
- Stage:Debt Financing, Private Equity, Series A
- Geography: United States, Canada, Australia
Investor stats
- Total investments: 23
- Lead/follow: 9% lead, 91% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- US Fertility — US Fertility brings together the brightest minds in reproductive medicine to achieve the highest clinical standards and pregnancy rates in the country. Discover excellence in fertility care today.
- Action Behavior Centers — Action Behavior Centers is a center-based provider of ABA therapy for children on the moderate to severe end of the autism spectrum.
- Choice Insurance Agency — Choice Insurance offers insurance solutions for your home, auto, business, and life. Discover how we can help to safeguard your financial future. Call Us.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Oceania investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Oceania Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!